Home > Healthcare > Healthcare IT > Healthcare Outsourcing > Virtual Clinical Trials Market

Virtual Clinical Trials Market Share

  • Report ID: GMI8438
  • Published Date: Mar 2024
  • Report Format: PDF
 Download Free Sample

Virtual Clinical Trials Market Share

The virtual clinical trials industry is characterized by the presence of several key players offering innovative solutions. Companies offer diverse solutions ranging from virtual trial platforms to telemedicine services, aiming to streamline trial processes, enhance patient engagement, and optimize data collection. Advancements in technology such as wearables, remote monitoring, and digital data management further intensify competition.
 

Key factors influencing competitiveness include regulatory compliance, data security, scalability, and integration capabilities. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.
 

Virtual Clinical Trials Market Companies

Prominent players operating in the virtual clinical trials industry include:

  • Clinical Ink
  • CROPRIME Ltd
  • ICON, plc
  • IQVIA Inc.
  • Medable, Inc.
  • Medidata
  • Oracle Corporation
  • Parexel International (MA) Corporation
  • PRA Health Sciences
  • Signant Health
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global virtual clinical trials industry was valued at USD 8.6 billion in 2023 and is predicted to reach USD 16.1 billion by 2032, attributed to the adoption of remote monitoring technologies, rise in R&D activities, as well as increasing healthcare digitization.

The fully virtual trials segment is expected to register 7% CAGR from 2024 to 2032 owing to the integration of digital health solutions, such as electronic patient-reported outcomes (ePRO), remote informed consent platforms, and virtual trial management systems that facilitate the implementation of the virtual clinical trials.

North America virtual clinical trials industry accounted for USD 3.7 billion in 2023 and is anticipated to observe 6.9% CAGR between 2024 and 2032 attributed to the increasing prevalence of cardiovascular disorders and a growing elderly population.

Clinical Ink, CROPRIME Ltd, ICON, plc, IQVIA Inc., Medable, Inc., Medidata, Oracle Corporation, Parexel International (MA) Corporation, PRA Health Sciences, and Signant Health.

Virtual Clinical Trials Market Scope

  • Virtual Clinical Trials Market Size
  • Virtual Clinical Trials Market Trends
  • Virtual Clinical Trials Market Analysis
  • Virtual Clinical Trials Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 10
    • Tables & Figures: 311
    • Countries covered: 19
    • Pages: 210
     Download Free Sample
    ×
    Get a free sample of Virtual Clinical Trials Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.